帕维拉治疗 PVLA
$175.92 +$19.07 (+12.16%)
休市 · Nov 7, 9:10 am ET · 最新盘后价 $175.92 0.00%
开盘$158.01
昨收$156.85
当日区间$156.54 – $176.94
成交量502.0K
市值$2.57B
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$0.00
营业利润-$21.41M-131.4% YoY
净利润-$21.87M-130.9% YoY
摊薄每股收益-$1.52-76.7% YoY
自由现金流-$12.85M-136.4% YoY
经营现金流-$12.85M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
净资产收益率-46.6%
资产收益率-37.7%
投入资本回报率-43.9%
流动比率21.18
负债/资产比率14.5%
现金及投资$250.58M
总负债$318,000.00
净现金（净负债）$250.27M
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 营业总收入 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 营业费用 | $21.41M | $14.86M | $38.60M | $11.30M | $10.18M |
| 销售及管理费用 | $8.93M | $5.52M | $15.76M | $4.18M | $3.65M |
| -管理费用 | $8.93M | $5.52M | $15.76M | $4.18M | $3.65M |
| 研发费用 | $12.47M | $9.33M | $22.84M | $7.12M | $6.53M |
| 营业利润 | -$21.41M | -$14.86M | -$38.60M | -$11.30M | -$10.18M |
| 非经营性利息净收入（支出） | -$343,000.00 | -$966,000.00 | -$3.23M | -$1.22M | -$882,000.00 |
| 非经营性利息收入 | $1.97M | $1.07M | $2.59M | $520,000.00 | $628,000.00 |
| 非经营性利息支出 | $2.31M | $2.04M | $5.82M | $1.74M | $1.51M |
| 其他收入（支出） | -$122,000.00 | $54,000.00 | $115,000.00 | -$191,000.00 | -$286,000.00 |
| 证券出售收益 | -$114,000.00 | $86,000.00 | -$612,000.00 | -$99,000.00 | -$320,000.00 |
| 其他非经营性收入（支出） | -$8,000.00 | -$32,000.00 | $727,000.00 | -$92,000.00 | $34,000.00 |
| 税前利润 | -$21.87M | -$15.77M | -$41.72M | -$12.71M | -$11.35M |
| 税费 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 净利润 | -$21.87M | -$15.77M | -$41.72M | -$12.71M | -$11.35M |
| 持续经营利润 | -$21.87M | -$15.77M | -$41.72M | -$12.71M | -$11.35M |
| 归属母公司净利润 | -$21.87M | -$15.77M | -$41.72M | -$12.71M | -$11.35M |
| 归属普通股股东净利润 | -$21.87M | -$15.77M | -$41.72M | -$12.71M | -$11.35M |
| 基本每股收益 | -$1.52 | -$1.20 | -$3.71 | -$1.08 | -$1.03 |
| 摊薄每股收益 | -$1.52 | -$1.20 | -$3.71 | -$1.08 | -$1.03 |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $253.51M | $263.76M | $59.56M | $59.56M | $66.94M |
| 流动资产合计 | $253.03M | $263.23M | $58.99M | $58.99M | $66.94M |
| 现金及现金等价物与短期投资 | $250.58M | $261.85M | $57.98M | $57.98M | $63.57M |
| -现金及现金等价物 | $187.80M | $206.39M | $57.98M | $57.98M | $63.57M |
| -短期投资 | $62.78M | $55.46M | – | – | – |
| 其他流动资产 | $2.44M | $1.38M | $1.01M | $1.01M | $1.15M |
| 非流动资产合计 | $482,000.00 | $528,000.00 | $572,000.00 | $572,000.00 | $0.00 |
| 固定资产净值 | $482,000.00 | $528,000.00 | $572,000.00 | $572,000.00 | – |
| -固定资产原值 | $482,000.00 | $528,000.00 | $572,000.00 | $572,000.00 | – |
| 负债合计 | $36.64M | $31.45M | $31.58M | $31.58M | $28.26M |
| 流动负债合计 | $11.95M | $9.12M | $11.34M | $11.34M | $10.31M |
| 应付款 | $6.79M | $5.44M | $4.60M | $4.60M | $3.48M |
| -应付账款 | $6.79M | $5.44M | $4.60M | $4.60M | $3.48M |
| 一年内应计费用 | $2.23M | $1.83M | $1.73M | $1.73M | $2.32M |
| 短期债务及融资租赁负债 | $217,000.00 | $209,000.00 | $202,000.00 | $202,000.00 | – |
| -一年内到期融资租赁负债 | $217,000.00 | $209,000.00 | $202,000.00 | $202,000.00 | – |
| 其他流动负债 | $1.24M | $960,000.00 | $2.90M | $2.90M | $3.27M |
| 非流动负债合计 | $24.70M | $22.33M | $20.23M | $20.23M | $17.94M |
| 长期债务及融资租赁负债 | $318,000.00 | $375,000.00 | $431,000.00 | $431,000.00 | – |
| -长期融资租赁负债 | $318,000.00 | $375,000.00 | $431,000.00 | $431,000.00 | – |
| 衍生产品负债 | $2.27M | $2.16M | $2.04M | $2.04M | $1.92M |
| 其他非流动负债 | $22.11M | $19.80M | $17.76M | $17.76M | $16.02M |
| 股东权益合计 | $216.87M | $232.31M | $27.98M | $27.98M | $38.68M |
| 股东权益 | $216.87M | $232.31M | $27.98M | $27.98M | $38.68M |
| 股本 | $14,000.00 | $14,000.00 | $12,000.00 | $12,000.00 | $11,000.00 |
| -普通股 | $14,000.00 | $14,000.00 | $12,000.00 | $12,000.00 | $11,000.00 |
| 资本公积 | $389.85M | $383.42M | $163.34M | $163.34M | $161.30M |
| 留存收益 | -$173.09M | -$151.22M | -$135.45M | -$135.45M | -$122.74M |
| 不影响留存收益的损益 | $89,000.00 | $95,000.00 | $83,000.00 | $83,000.00 | $104,000.00 |
| 应收款 | – | – | $0.00 | $0.00 | $2.22M |
| -应收账款 | – | – | $0.00 | $0.00 | $0.00 |
| -应收税款 | – | – | $0.00 | $0.00 | $2.22M |
| -优先股 | – | – | $0.00 | $0.00 | $0.00 |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$12.85M | -$10.86M | -$25.01M | -$4.93M | -$7.88M |
| 持续经营经营活动现金流净额 | -$12.85M | -$10.86M | -$25.01M | -$4.93M | -$7.88M |
| 持续经营净利润 | -$21.87M | -$15.77M | -$41.72M | -$12.71M | -$11.35M |
| 持续经营损益 | $114,000.00 | -$86,000.00 | $612,000.00 | $99,000.00 | $320,000.00 |
| 其他非现金项目 | $1.98M | $2.02M | $5.88M | $1.80M | $1.51M |
| 营运资金变动 | $1.77M | -$406,000.00 | $3.82M | $3.80M | -$153,000.00 |
| -预付资产变动 | -$1.07M | -$357,000.00 | $1.36M | $222,000.00 | -$176,000.00 |
| -应付账款及应计费用变动 | $2.84M | -$49,000.00 | -$40,000.00 | $1.45M | -$335,000.00 |
| 投资活动现金流净额 | -$7.03M | -$55.44M | – | – | – |
| 持续经营投资活动现金流净额 | -$7.03M | -$55.44M | – | – | – |
| 投资购置及出售净额 | -$7.03M | -$55.44M | – | – | – |
| 筹资活动现金流 | $1.28M | $214.73M | -$660,000.00 | -$49,000.00 | $242,000.00 |
| 持续经营筹资活动现金流净额 | $1.28M | $214.73M | -$660,000.00 | -$49,000.00 | $242,000.00 |
| 普通股发行净额 | $0.00 | $230.00M | – | – | – |
| 股票期权行使所得 | $1.28M | $956,000.00 | $763,000.00 | $105,000.00 | $242,000.00 |
| 其他筹资费用净额 | $0.00 | -$16.23M | -$1.42M | -$154,000.00 | $0.00 |
| 期末现金余额 | $187.80M | $206.39M | $57.98M | $57.98M | $63.57M |
| 现金净变动 | -$18.60M | $148.43M | -$25.67M | -$4.98M | -$7.64M |
| 期初现金余额 | $206.39M | $57.98M | $83.60M | $63.57M | $70.43M |
| 汇率变动影响 | $6,000.00 | -$15,000.00 | $46,000.00 | -$610,000.00 | $770,000.00 |
| 自由现金流 | -$12.85M | -$10.86M | -$25.01M | -$4.93M | -$7.88M |
| -应收款变动 | – | – | $2.49M | $2.13M | – |
| 债务发行及偿还净额 | – | – | $0.00 | $0.00 | – |
暂无评论——快来第一个聊聊 PVLA。
登录后参与讨论。